I know we talk about this, but you really have to consider the market in AMRN's SP fight. Overlay XBI and AMRN today. They are literally in lockstep, tick for tick.
XBI is down exactly 50% in the past 16 months. AMRN is down like 60%. And AMRN tracked it down almost in lockstep the whole way from 01/01/21.
It's absolutely not an excuse for any of their operational f-ups. But the point is, if XBI had been UP, say 20% the past 16 months (and AMRN was still tracking it), then maybe AMRN is at $8.75 instead of $2.75.
I'm not sure what this really means going forward, but absent any MAJOR triggers, AMRN is not going to break out until XBI does. So I think we all need to pray to the Biotech Gods for a major index breakout, sooner rather than later.
Market Data 
Markets 
AI
